SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-065445
Filing Date
2024-05-28
Accepted
2024-05-28 11:43:29
Documents
10
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2415640d1_6k.htm 6-K 11615
2 EXHIBIT 99.1 tm2415640d1_ex99-1.htm EX-99.1 15173
3 EXHIBIT 99.2 tm2415640d1_ex99-2.htm EX-99.2 786220
4 EXHIBIT 99.3 tm2415640d1_ex99-3.htm EX-99.3 7146
5 EXHIBIT 99.4 tm2415640d1_ex99-4.htm EX-99.4 8037
6 GRAPHIC image_006.jpg GRAPHIC 5159
7 GRAPHIC tm2415640d1_ex99-2sp001img01.jpg GRAPHIC 27444
8 GRAPHIC tm2415640d1_ex99-2sp001img02.jpg GRAPHIC 88533
9 GRAPHIC tm2415640d1_ex99-3img001.jpg GRAPHIC 172884
10 GRAPHIC tm2415640d1_ex99-3img002.jpg GRAPHIC 184922
  Complete submission text file 0001104659-24-065445.txt   1489605
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 24988300
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)